Portfolio Management Services (PMS)Compare Schemes
Carnelian Capital - Compounder Strategy vs Valcreate Lifesciences and Specialty Opportunities
Add SchemeGrowth of ₹1 Crore
Carnelian Capital - Compounder Strategy
Valcreate Lifesciences and Specialty Opportunities
Return for the risk
3 yrs return
5%
10%
15%
20%
25%
30%
Nifty 500 · 12.1%
10%
20%
30%
Volatility • 3 yrs deviation
1 Month
4.57%
6.35%
6 Months
15.76%
17.95%
1 Year
22.36%
21.71%
3 Years
23.83%
19.34%
5 Years
17.53%
—
Since Inception
20.07%
19.34%
Fund Age
7 yrs 3 mo
3 yrs 6 mo
AUM
₹2,271.9 Cr
₹18.73 Cr
Alpha – 1 Year
17.64%
16.99%
Alpha – 3 Years
11.75%
7.25%
Information Ratio – 3 Years
1.40
0.85
Volatility – 1 Year
21.11%
22.22%
Volatility – 3 Years
18.96%
20.72%
Beta – 1 Year
1.17
0.87
Beta – 3 Years
1.12
0.89
Sharpe Ratio – 1 Year
0.81
0.75
Sharpe Ratio – 3 Years
0.96
0.85
Worst Rolling Year
10.25%
—
Value at Worst Rolling Year
₹1.10 Cr
—
Deepest Drawdown
−19.83%
—
Recovery Period
123 days
—
1-Year Rolling Windows Positive
100.00%
—
Median Rolling Year
21.55%
—
5-Year Rolling Windows Positive
100.00%
—
Market-Cap Mix
L 30% · M 46% · S 22%
—
Number of Stocks
30
—
Portfolio P/E
29.80
—
Top 5 Holdings
Aditya Birla Capital Ltd · 10.17%
Laurus Labs Ltd · 8.63%
Biocon Ltd · 7.50%
One 97 Communications Ltd · 4.59%
Bharat Heavy Electricals Ltd · 4.29%
Sharda Cropchem Ltd · 11.13%
Kwality Pharmaceuticals Ltd · 5.72%
Sumitomo Chemical India Ltd · 5.72%
Vinati Organics Ltd · 5.51%
Rallis India Ltd · 5.34%
Top Sectors
—
—
Fixed Fee
2.50% / yr
2.50% / yr
Performance Fee / Plan
Fixed Plan
Fixed Plan
Exit Load (Y1 / Y2 / Y3)
1% / 0% / 0%
0% / 0% / 0%